Anxiety disorder
97 results
1 - 97
CBT, sertraline, and combination effective for childhood anxiety disorders- Useful screening tools for generalized anxiety and panic disorder
- First-line treatment for social anxiety disorder: cognitive behavioral therapy
- Mindfulness-based stress reduction is noninferior to escitalopram for adults with anxiety disorder
- Escitalopram (Lexapro) minimally effective for generalized anxiety disorder in older adults
- One third of patients with anxiety disorder will relapse when SSRI/SNRI treatment stops
- Multiple drugs in several classes are effective and well tolerated in patients with generalized anxiety disorder
- USPSTF 2022: Screening for anxiety is recommended in children and adolescents aged 8 to 18 years (B recommendation)
- Eszopiclone and escitalopram useful for anxiety and insomnia
- USPSTF 2023: Screening recommended for anxiety in adults, including in pregnant and postpartum persons (B recommendation)
- Fluoxetine may offer advantages over other anxiety treatments
- Oral CBD promising for treatment of heroin use disorder
- Medical cannabis use not supported by a wealth of research
- Prenatal cannabis exposure is not associated with an increased incidence of several neuropsychiatric disorders
- Mental health improves after quitting smoking
- WONCA/Dartmouth COOP charts are useful for mental disorder screening
- Cognitive behavioral therapy can be effective when delivered in primary care settings
- Benefits and harms of atypical antipsychotics for off-label use
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- USPSTF: No recommendation for lipid disorder screening in patients 20 years or younger (I recommendation)
- Risk of major depressive disorder high after traumatic brain injury
- There is little data about the usefulness of mobile device applications for managing children with autism spectrum disorder
- Vitamin D replacement increases blood levels but doesn't affect fatigue
- Delivery of bad news via phone = in-person delivery
- Proactive communication strategy reduces stress in families of dying patients
- Relapse of depression more likely after discontinuation of medication (number needed to treat to harm = 6).
- Acamprosate and oral naltrexone are useful for the treatment of alcohol use disorder
- Comprehensive intervention in childhood reduces adult psychopathology
- USPSTF 2017 does not recommend for or against screening for celiac disease in asymptomatic patients (I statement)
- USPSTF 2018: evidence insufficient to recommend for or against idiopathic scoliosis screening (I recommendation)
- USPSTF 2023: Evidence insufficient to recommend lipid screening in children and adolescents (I statement)
- Problem-solving therapy effective for depression with executive dysfunction
- Palliative care consultation benefits stem cell transplant patients
- A 7-day course in cognitive behavioral therapy leads to implementation of skills and strategies in practice
- Mirtazapine does not reduce agitated behaviors in persons with dementia (SYMBAD)
- Treating opioid use disorder in primary care—limited data, but looks feasible
- Intensive therapy = standard weekly cognitive therapy for PTSD
- Generic anticonvulsants assoc with worse outcomes, higher expense than brand